Role of PARP Inhibitors in BRCA-Related Malignancies
Frontiers | PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
JCM | Free Full-Text | PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
JCI - The evolving landscape of predictive biomarkers of response to PARP inhibitors
Frontiers | Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
Epigenetic marker contributes to PARP inhibitor resistance | Center for Cancer Research
The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment
Frontiers | The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions | British Journal of Cancer
Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review)
PARP inhibitors stumble in breast cancer | Nature Biotechnology
An update on PARP inhibitors—moving to the adjuvant setting | Nature Reviews Clinical Oncology
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect
Mechanisms of resistance to PARP inhibitors. Cancer cells develop... | Download Scientific Diagram
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
How PARP inhibitors (PARPi) work - YouTube
PARP-inhibitors: A New Generation of Cancer Drugs - YouTube
Cancers | Free Full-Text | Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors
Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors | Bentham Science
PARP inhibitor combination therapy - ScienceDirect
